Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

405
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

583
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

343
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Drug Therapy01:28

Drug Therapy

353
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
353
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

304
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

646
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
646

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential Associations of Adversity and Victimisation With Psychotic Experiences in Autistic Adolescents.

Journal of autism and developmental disorders·2026
Same author

Child and adolescent psychiatry: Challenges and Advances in Youth Mental Health.

Anales de pediatria·2026
Same author

Consensus document on the treatment of insomnia in patients with autism spectrum disorder under 18 years of age.

Anales de pediatria·2026
Same author

Invasive bacterial infection in febrile neonates with influenza infection.

Anales de pediatria·2025
Same author

Impact of screen and social media use on mental health.

Anales de pediatria·2025
Same author

Eating disorders: Involvement of pediatricians in their prevention, early detection, evaluation and multidisciplinary management.

Anales de pediatria·2025

Related Experiment Video

Updated: Mar 8, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.9K

Psychotropic medications in Pediatric practice.

Pedro Javier Rodríguez Hernández1, Gemma Ochando Perales2, César Soutullo Esperón3

  • 1Hospital de Día Infantil y Juvenil «Diego Matías Guigou y Costa», Servicio de Psiquiatría, Hospital Universitario Ntra. Sra. de Candelaria, Universidad de La Laguna, Sociedad de Psiquiatría Infantil de la AEP, Tenerife, Spain.

Anales De Pediatria
|March 6, 2026
PubMed
Summary
This summary is machine-generated.

This review covers common psychotropic medications for pediatric mental health conditions. Understanding these drugs, including those for attention-deficit/hyperactivity disorder (ADHD), depression, anxiety, and behavioral disorders, is crucial.

Keywords:
Child psychiatryMental healthPediatric psychopharmacologyPsicofarmacología pediátricaPsiquiatría infantilSalud mental

More Related Videos

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.7K
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K

Related Experiment Videos

Last Updated: Mar 8, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.9K
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.7K
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K

Area of Science:

  • Child and Adolescent Psychiatry
  • Pediatric Psychopharmacology

Background:

  • Increasing prevalence of mental health disorders in children and adolescents.
  • Necessity for understanding available psychotropic treatments in pediatric populations.

Purpose of the Study:

  • To review the most commonly prescribed psychotropic medications for pediatric patients.
  • To outline indications for these medications in treating childhood and adolescent mental health conditions.

Main Methods:

  • Literature review of psychotropic medications used in children and adolescents.
  • Focus on frequently prescribed drug classes and their therapeutic uses.

Main Results:

  • Stimulant and nonstimulant medications are frequently used for attention-deficit/hyperactivity disorder (ADHD).
  • Selective serotonin reuptake inhibitors (SSRIs) are common for pediatric depression and anxiety.
  • Antipsychotic medications are prescribed for behavioral disorders in this age group.

Conclusions:

  • Key psychotropic medication classes for pediatric mental health include ADHD treatments, SSRIs, and antipsychotics.
  • Awareness of these medications and their indications is vital for managing pediatric mental health disorders.